U.S. Online Retail and Ecommerce Stock News

NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase Ties Olympic Banking Deal To Long Term Growth Story

JPMorgan Chase (NYSE:JPM) has become the first Global Banking Partner of the Olympic Games through a new agreement with the International Olympic Committee. The partnership covers the LA28 Olympic and Paralympic Games and the French Alps 2030 Olympic and Paralympic Games. The bank plans to support athletes and local communities through financial education, local business investment, and storytelling initiatives with NBCUniversal. For a global universal bank like JPMorgan Chase, this Olympic...
OTCPK:PSBQ
OTCPK:PSBQBanks

PSB Holdings (OTCPK:PSBQ) Margin Improvement Challenges Long Term Earnings Decline Narrative

PSB Holdings (PSBQ) opened Q1 2026 with total revenue of US$13.24 million and basic EPS of US$0.82, against a share price of US$27.29, setting the tone for another data rich update for bank focused investors. The company reported quarterly revenue increasing from US$12.00 million in Q1 2025 to US$13.24 million in Q1 2026. Over the same period, basic EPS rose from US$0.60 to US$0.82, with trailing twelve month EPS at US$3.54 as margins moved from 22.8% to 27.2% over the past year. Overall, the...
NYSE:GS
NYSE:GSCapital Markets

Assessing Goldman Sachs (GS) Valuation After Strong 1 Year Shareholder Returns

Why Goldman Sachs Group (GS) Is On Investor Radar Today Goldman Sachs Group (GS) has been drawing attention after recent share price moves, with the stock last closing at US$926.55 and showing mixed returns over the past month and past 3 months. See our latest analysis for Goldman Sachs Group. Despite a 1.2% single day share price decline, the recent 15.4% 1 month share price return and strong 1 year total shareholder return of 72.29% suggest momentum has generally been building over time. If...
NYSE:VZ
NYSE:VZTelecom

Verizon World Cup 2026 Push Tests 5G Network And Investor Expectations

Verizon Communications (NYSE:VZ) is expanding its role as the Official Telecom Sponsor for the FIFA World Cup 2026. The company is rolling out extensive 5G and network upgrades, community programs, and digital infrastructure projects across host cities ahead of the tournament. The partnership includes support for public safety agencies and connectivity solutions for businesses tied to World Cup activity. Verizon enters this World Cup buildout with NYSE:VZ trading at $47.24, after a 16.6%...
NYSE:LOW
NYSE:LOWSpecialty Retail

A Look At Lowe's (LOW) Valuation As Shares Trade Near Narrative And DCF Fair Value Estimates

Lowe's Companies (LOW) continues to attract attention as investors weigh its recent share performance, with a last close of $240.32 and mixed short term returns against longer term total returns and current earnings and revenue levels. See our latest analysis for Lowe's Companies. Recent trading has been choppy, with a 7 day share price return of 4.33% decline and a 90 day share price return of 10.80% decline. However, the 1 year total shareholder return of 9.75% points to steadier long term...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault Systems (CVLT) Margins At 6% Test Bullish Earnings Growth Narrative

Commvault Systems (CVLT) closed out FY 2026 with fourth quarter revenue of US$311.7 million, basic EPS of US$0.34 and net income of US$14.6 million, set against a trailing 12 month picture that includes a 6% net margin and a one off loss of US$31.6 million. Over the last six quarters, the company has seen quarterly revenue move from US$262.6 million in Q3 FY 2025 to a trailing 12 month total of US$1.18 billion. Basic EPS across individual quarters ranged between US$0.25 and US$0.70 and...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services (UHS) Margin Improvement Challenges Cautious Earnings Forecasts In Q1 2026

Universal Health Services (UHS) opened Q1 2026 with total revenue of US$4.5 billion, basic EPS of US$5.71 and net income of US$348.7 million, setting a clear marker for how the year is starting. The company has seen quarterly revenue move from US$4.1 billion and EPS of US$4.87 in Q1 2025 to US$4.5 billion and EPS of US$5.71 in Q1 2026. Trailing twelve month EPS reached US$24.29 on revenue of US$17.8 billion. With net profit margins running at 8.6% over the last year, the latest results give...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest (ARCB) Q1 Loss And 1.4% TTM Margin Test Profitability Narratives

ArcBest (ARCB) opened 2026 with Q1 revenue of US$998.8 million and a small net loss of US$1.0 million, which translated to basic EPS of a US$0.05 loss. Over the past few quarters, revenue has ranged between US$967.1 million and US$1.0 billion, while basic EPS has swung from a profit of US$1.24 in Q4 2024 to a loss of US$0.36 in Q4 2025 and now a much narrower loss in Q1 2026. This sets up a quarter in which investors are likely to focus on how margins are holding up through the cycle. See our...
NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

A Look At SEALSQ (LAES) Valuation After New Post Quantum Security And Vertical Stack Updates

SEALSQ (LAES) has drawn fresh attention after detailing how its chips aim to embed Post Quantum Cryptography directly into hardware, responding to rising AI driven cyber risks and the longer term threat from quantum computing. See our latest analysis for SEALSQ. The recent PQC hardware update lands after a busy stretch for SEALSQ, with Quantum Vertical Stack plans, quantum networking projects, and autonomous quantum lab progress all in focus. Despite this, the 90 day share price return is a...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

Will Progyny Select’s Small-Employer Fertility Launch Redefine Progyny's (PGNY) Risk-Pooling Narrative?

Earlier this month, Progyny, Inc. launched Progyny Select, a fully insured supplemental fertility and family-building plan designed to give small U.S. employers access to comprehensive, fixed-premium fertility and women’s health coverage through brokers, health plans, and general agents for the 2027 plan year. The plan packages Progyny’s managed provider network, Smart Cycle benefit design, and concierge care advocates into a pooled-risk model that aims to lower financial and structural...
NYSE:BLCO
NYSE:BLCOMedical Equipment

A Look At Bausch + Lomb (BLCO) Valuation As AGM Silence Raises Governance Questions

Bausch + Lomb (BLCO) has been drawing attention after recent trading left the shares around $15.72, with a mixed pattern of returns across the past week, month, past 3 months, and year to date. See our latest analysis for Bausch + Lomb. The recent US$15.72 share price sits against a mixed backdrop, with a 30 day share price return of 2.28%, a 90 day share price return of 6.21%, and a 3 year total shareholder return of 10.07%. This suggests momentum has cooled, even though the 1 year total...
NYSE:ICE
NYSE:ICECapital Markets

A Look At Intercontinental Exchange (ICE) Valuation As Analyst Optimism Builds Around Upcoming Earnings

Why Intercontinental Exchange is Back in Focus Intercontinental Exchange (ICE) is back on investors’ radar after recent analyst commentary pointed to expectations for improved first quarter 2026 results, driven by data services, exchange activity, and mortgage technology. See our latest analysis for Intercontinental Exchange. While the 1 day share price return of 0.41% decline and 7 day return of 1.47% decline suggest short term pressure, the 3 year total shareholder return of 51.55% and 5...
NYSE:NIC
NYSE:NICBanks

A Look At Nicolet Bankshares (NIC) Valuation After Q1 Results And Capital Return Updates

Nicolet Bankshares (NIC) released first quarter 2026 results that show higher net interest income alongside lower net income and earnings per share, rising net loan charge-offs, an increased quarterly dividend, and continued activity under its long running share repurchase plan. See our latest analysis for Nicolet Bankshares. At a share price of $148.58, the stock has a year to date share price return of 23.31%, while the 1 year total shareholder return of 27.02% sits against a very large 3...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Assessing Coupang (CPNG) Valuation After Recent Share Price Momentum And Margin Expectations

Coupang (CPNG) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past year but a gain over the past month. Investors are weighing these swings against its latest financial profile. See our latest analysis for Coupang. With the share price at US$20.34, Coupang has seen a 12.44% 1 month share price return, while the year to date share price return and 1 year total shareholder return are both in decline, suggesting recent momentum is...
NYSE:PSN
NYSE:PSNProfessional Services

A Look At Parsons (PSN) Valuation After Winning The US$4.6b SR 400 Express Lanes Lead Designer Role

Parsons (PSN) shares have been in focus after the company took the lead designer role on Georgia’s SR 400 Express Lanes Project, a roughly US$4.6b public private partnership for new express lanes. See our latest analysis for Parsons. Despite securing several large infrastructure and government contracts in recent weeks, Parsons’ recent 90 day share price return of a 27.71% decline and 1 year total shareholder return of a 24.50% decline suggest momentum has cooled after stronger multi year...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments TI 84 Evo Launch Highlights Calculator Strength And Valuation Risk

Texas Instruments (NasdaqGS:TXN) has introduced the TI-84 Evo Graphing Calculator, the latest and most advanced model in its TI-84 series. The device targets middle school, high school, and college students with a faster processor, expanded graphing capacity, and a redesigned keypad. The TI-84 Evo is approved for use on major standardized exams, positioning it for broad adoption across classrooms and testing centers. For Texas Instruments, known for its analog and embedded processing chips,...
NasdaqGS:CBC
NasdaqGS:CBCBanks

Central Bancompany (CBC) Net Margin Improvement Tests Bullish Profitability Narratives

Central Bancompany (CBC) opened Q1 2026 with total revenue of US$270.6 million and basic EPS of US$0.46, setting the tone for another earnings update that will have investors watching the income line and per share profitability closely. Over recent quarters, the company has seen revenue move from US$203.8 million in Q4 2024 to US$245.1 million in Q1 2025 and US$270.6 million in Q1 2026, while quarterly EPS shifted from US$0.28 to US$0.43 and now US$0.46, giving useful context alongside...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

SEC Rule Shift On Day Trading And Margin Resets Interactive Brokers Outlook

The US SEC has removed the Pattern Day Trader rule, allowing unlimited day trading for accounts under $25,000. The rule change also permits up to 4x margin buying power for eligible accounts. This regulatory shift directly affects brokers such as Interactive Brokers Group (NasdaqGS:IBKR) and the wider retail trading industry. Interactive Brokers Group, trading at around $77.49, now faces a different operating backdrop as retail clients gain more flexibility to trade frequently with higher...
NasdaqGS:NWBI
NasdaqGS:NWBIBanks

Northwest Bancshares (NWBI) Q1 Cost Efficiency Jump Tests Bullish Earnings Growth Narrative

Northwest Bancshares (NWBI) opened 2026 with Q1 revenue of US$170.7 million and basic EPS of US$0.35, underpinned by net income of US$50.5 million and a net interest margin of 3.7%. Over recent periods, the company has seen quarterly revenue move from US$148.3 million in Q1 2025 to US$172.2 million in Q4 2025 and then to US$170.7 million in Q1 2026, while basic EPS shifted from US$0.34 in Q1 2025 to US$0.31 in Q4 2025 and US$0.35 in the latest quarter. With a current net profit margin of...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

A Look At CrowdStrike Holdings (CRWD) Valuation After Mizuho Upgrade And AI Security Product Momentum

Mizuho’s upgrade of CrowdStrike Holdings (CRWD) to Outperform, citing healthy demand and AI security leadership, has put fresh attention on the stock as investors consider how recent product moves factor into the story. See our latest analysis for CrowdStrike Holdings. Despite the recent analyst upgrade and a string of AI-focused product announcements, CrowdStrike’s 30-day share price return of 23.11% contrasts with a modest 0.31% year to date. The 3-year total shareholder return of roughly...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA Faces New China Export Curbs With Valuation Risk In Focus

The US Department of Commerce has ordered KLA and some sector peers to halt shipments of certain tools to Chinese chipmaker Hua Hong. The move tightens existing US China semiconductor trade restrictions and directly affects KLA’s ability to supply a key customer in China. This development raises fresh questions about KLA’s future access to the Chinese market and potential revenue tied to restricted tools. KLA, listed on NasdaqGS:KLAC, is entering this new regulatory phase with a strong...
NYSE:MMM
NYSE:MMMIndustrials

3M’s Artemis II Role Highlights Space Uses And Valuation Debate

3M’s PELTOR ComTac VI Tactical Headsets are being used by the NASA Artemis II crew for mission-critical communications. 3M materials have been integrated into the liquid hydrogen tank insulation for the mission’s launch systems. This extends 3M’s technology into high-profile space exploration, beyond its traditional industrial use cases. The connection to NASA’s Artemis II mission gives investors a fresh data point on how 3M (NYSE:MMM) technology is being applied in demanding environments...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Is It Time To Reassess Fannie Mae (OTCPK:FNMA) After Its Recent Share Price Surge?

This article examines whether Federal National Mortgage Association is priced fairly or if the market is overlooking something, by considering what the current share price might be indicating about value. The stock last closed at US$7.66, with a 2.9% decline over 7 days, a 57.6% gain over 30 days, a 30.4% decline year to date, a 20.1% return over 1 year, a very large return over 3 years, and a 256.3% return over 5 years. Recent coverage has focused on how Federal National Mortgage...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Expands Into AI DNA Editing With Profluent Enzyme Deal

Eli Lilly (NYSE:LLY) has entered a multi billion dollar partnership with Profluent to develop AI designed enzymes for genetic medicines. The collaboration focuses on creating custom enzymes that aim to support more precise and scalable DNA editing for hard to treat diseases. The deal marks a move by Lilly to broaden its research focus beyond GLP 1 therapies and oncology into AI driven DNA editing therapeutics. Eli Lilly has built a high profile position in obesity and diabetes treatments...